Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11638]

New micromaterial releases nanoparticles that selectively destroy cancer cells

New micromaterial releases nanoparticles that selectively destroy cancer cells

AACR 2024: Preliminary study finds immunotherapy combination before surgery improves outcomes for patients with pancreatic cancer

AACR 2024: Preliminary study finds immunotherapy combination before surgery improves outcomes for patients with...

Microbial signature of colorectal cancer-associated mutations identified in new study

Microbial signature of colorectal cancer-associated mutations identified in new study

Research details adaptation tactics of pancreatic cancer

Research details adaptation tactics of pancreatic cancer

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive solid tumours

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive...

Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer

Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer

EAU 2024: Five-year interval is safe for prostate cancer screening, research shows

EAU 2024: Five-year interval is safe for prostate cancer screening, research shows

New study targets major risk factor for gastric cancer

New study targets major risk factor for gastric cancer

Researchers awarded grant to develop genetic risk score for thyroid cancer

Researchers awarded grant to develop genetic risk score for thyroid cancer

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy and assessing t-cell exhaustion

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer...

More from ecancer